These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 19409390)

  • 1. Fluoxetine potentiates the effects of corticotropin-releasing factor on locomotor activity and serotonergic systems in the roughskin newt, Taricha granulosa.
    Lowry CA; Hale MW; Burke KA; Renner KJ; Moore FL
    Horm Behav; 2009 Jun; 56(1):177-84. PubMed ID: 19409390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluoxetine inhibits corticotropin-releasing factor (CRF)-induced behavioural responses in rats.
    Lowry CA; Hale MW; Plant A; Windle RJ; Shanks N; Wood SA; Ingram CD; Renner KJ; Lightman SL; Summers CH
    Stress; 2009 May; 12(3):225-39. PubMed ID: 18951247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticotropin-releasing factor (CRF) stimulates locomotor activity in intact and hypophysectomized newts (Amphibia).
    Moore FL; Roberts J; Bevers J
    J Exp Zool; 1984 Sep; 231(3):331-3. PubMed ID: 6334126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticotropin-releasing factor (CRF) antagonist suppresses stress-induced locomotor activity in an amphibian.
    Lowry CA; Moore FL
    Horm Behav; 1991 Mar; 25(1):84-96. PubMed ID: 1646155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid changes in monoamine levels following administration of corticotropin-releasing factor or corticosterone are localized in the dorsomedial hypothalamus.
    Lowry CA; Burke KA; Renner KJ; Moore FL; Orchinik M
    Horm Behav; 2001 May; 39(3):195-205. PubMed ID: 11300710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brainstem reticulospinal neurons are targets for corticotropin-releasing factor-Induced locomotion in roughskin newts.
    Hubbard CS; Dolence EK; Rose JD
    Horm Behav; 2010 Feb; 57(2):237-46. PubMed ID: 19968991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of brain target neurons using a fluorescent conjugate of corticotropin-releasing factor.
    Hubbard CS; Dolence EK; Shires JA; Rose JD
    J Chem Neuroanat; 2009 Jul; 37(4):245-53. PubMed ID: 19481009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of corticotropin-releasing factor (CRF) and opiates on amphibian locomotion.
    Lowry CA; Deviche P; Moore FL
    Brain Res; 1990 Apr; 513(1):94-100. PubMed ID: 2161698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Destruction of serotonergic nerve terminals prevents fluoxetine-induced desensitization of hypothalamic 5-HT(1A) receptors.
    D'Souza DN; Zhang Y; Garcia F; Battaglia G; Van De Kar LD
    Psychopharmacology (Berl); 2002 Dec; 164(4):392-400. PubMed ID: 12457269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin engages an anxiety and fear-promoting circuit in the extended amygdala.
    Marcinkiewcz CA; Mazzone CM; D'Agostino G; Halladay LR; Hardaway JA; DiBerto JF; Navarro M; Burnham N; Cristiano C; Dorrier CE; Tipton GJ; Ramakrishnan C; Kozicz T; Deisseroth K; Thiele TE; McElligott ZA; Holmes A; Heisler LK; Kash TL
    Nature; 2016 Sep; 537(7618):97-101. PubMed ID: 27556938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that acute serotonergic activation potentiates the locomotor-stimulating effects of corticotropin-releasing hormone in juvenile chinook salmon (Oncorhynchus tshawytscha).
    Clements S; Moore FL; Schreck CB
    Horm Behav; 2003 Jan; 43(1):214-21. PubMed ID: 12614652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of corticotropin-releasing factor on brain serotonergic activity.
    Price ML; Curtis AL; Kirby LG; Valentino RJ; Lucki I
    Neuropsychopharmacology; 1998 Jun; 18(6):492-502. PubMed ID: 9571657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluoxetine, but not sertraline or citalopram, potentiates the locomotor stimulant effect of cocaine: possible pharmacokinetic effects.
    Fletcher PJ; Sinyard J; Salsali M; Baker GB
    Psychopharmacology (Berl); 2004 Jul; 174(3):406-13. PubMed ID: 14740149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of serotonin release in the lateral septum and striatum by corticotropin-releasing factor.
    Price ML; Lucki I
    J Neurosci; 2001 Apr; 21(8):2833-41. PubMed ID: 11306635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticotropin-releasing factor enhances locomotion and medullary neuronal firing in an amphibian.
    Lowry CA; Rose JD; Moore FL
    Horm Behav; 1996 Mar; 30(1):50-9. PubMed ID: 8724179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrin-releasing peptide mediated regulation of 5-HT neuronal activity in the hypothalamic paraventricular nucleus under basal and restraint stress conditions.
    Garrido MM; Fuentes JA; Manzanares J
    Life Sci; 2002 May; 70(25):2953-66. PubMed ID: 12138009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticotropin releasing factor induces anxiogenic locomotion in trout and alters serotonergic and dopaminergic activity.
    Carpenter RE; Watt MJ; Forster GL; Øverli Ø; Bockholt C; Renner KJ; Summers CH
    Horm Behav; 2007 Dec; 52(5):600-11. PubMed ID: 17826776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional antagonism between nociceptin/orphanin FQ and corticotropin-releasing factor in rat anxiety-related behaviors: involvement of the serotonergic system.
    Filaferro M; Ruggieri V; Novi C; Calò G; Cifani C; Micioni Di Bonaventura MV; Sandrini M; Vitale G
    Neuropeptides; 2014 Aug; 48(4):189-97. PubMed ID: 24894718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoaminergic activity in subregions of raphé nuclei elicited by prior stress and the neuropeptide corticotropin-releasing factor.
    Summers CH; Kampshoff JL; Ronan PJ; Lowry CA; Prestbo AA; Korzan WJ; Renner KJ
    J Neuroendocrinol; 2003 Dec; 15(12):1122-33. PubMed ID: 14636174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corticotropin-releasing factor in the dorsal raphe nucleus increases medial prefrontal cortical serotonin via type 2 receptors and median raphe nucleus activity.
    Forster GL; Pringle RB; Mouw NJ; Vuong SM; Watt MJ; Burke AR; Lowry CA; Summers CH; Renner KJ
    Eur J Neurosci; 2008 Jul; 28(2):299-310. PubMed ID: 18702701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.